Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03082261 · ClinicalTrials.gov registry record · NA
Multi-center Prospective Study Determining the Sustainability of Pain Relief and Psychosocial and Functional Responses When Utilizing a Multiple Waveform Enabled Neurostimulator
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 269
- Enrollment target
NCT03082261 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 269 participants.
The verdict
NCT03082261, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 269 participants
- Enrollment target
Study Summary
The TRIUMPH study is a post-market, international, multicenter, interventional, prospective, single-arm study intended to evaluate the sustainability of pain control and psychosocial and functional responses utilizing a multiple-waveform enabled neurostimulator in subjects with chronic, intractable pain of the trunk and/or limbs.
Interventions
- DEVICE Prodigy, Prodigy MRI or Proclaim Elite IPG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 269 participants |
| Start Date | 2017-03-03 |
| Est. Completion | 2020-08-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03082261
The ClinicalTrials.gov registry entry for NCT03082261 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 269 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Prodigy, Prodigy MRI or Proclaim Elite IPG is the first listed.
NCT03082261 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03082261 about?
NCT03082261 is a clinical study titled "Multi-center Prospective Study Determining the Sustainability of Pain Relief and Psychosocial and Functional Responses When Utilizing a Multiple Waveform Enabled Neurostimulator". The TRIUMPH study is a post-market, international, multicenter, interventional, prospective, single-arm study intended to evaluate the sustainability of pain control and psychosocial and functional responses utilizing a multiple-waveform enabled neurostimulator in subjects with chronic, intractable ...
What is the current status of trial NCT03082261?
This trial is currently completed. It is a NA study. The enrollment target is 269 participants. The study started on 2017-03-03. Estimated completion is 2020-08-26.
What interventions are being tested in trial NCT03082261?
The interventions under investigation include: Prodigy, Prodigy MRI or Proclaim Elite IPG (DEVICE).
Who is sponsoring clinical trial NCT03082261?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.